On 24 October 2012 the Portuguese Ministry of Public Health (Direcção-Geral da Saúde) confirmed 52 cases of dengue fever and 404 probable cases, compared to 37 confirmed and 262 probable cases in their last update of 17 October.
The sixth European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) opened today at the Edinburgh International Conference Centre (EICC).
On 3 October, the Public Health Authority of Portugal (Direção-Geral da Saúde) reported two cases of dengue infection in patients residing in the Autonomous Region of Madeira, Portugal.
The authors assess the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011 (this period included a large outbreak in 2010).
ECDC publishes today a report surveying the prevalence of Tick Borne Encephalitis (TBE) in Europe. The report has epidemiological data from 2000 to 2010 for 20 out of 30 EU/EFTA countries. The data shows that a number of key risk areas can be found in Europe in terms of geographic spread, seasonal peaks and at-risk age groups. Most countries in Europe have surveillance systems although some vary which greatly impedes comparability and analysis of TBE.
On 5 September 2012 the European Commission decision amending Decision 2000/96/EC as regards tick-borne encephalitis was published. As a result tick-borne encephalitis is added to the list of diseases to be covered by epidemiological surveillance within the Community.
On 3 August 2012, a probable case of dengue infection was reported in a resident in west Greece (Agrinio). The 84 year old patient, who had severe underlying conditions and septicaemia, died on 30 August 2012.
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
ECDC, through the VBORNET network, publishes regularly on its website maps on exotic mosquitoes and on phlebetomines - to provide the ECDC stakeholders and the general public with the most updated information on vector distribution. The maps are updated and improved quarterly.